(Total Views: 244)
Posted On: 04/27/2022 11:06:11 AM
Post# of 1418
yup, yup, yup. Gerald has also mention 'transaction' a few times in regards to the external valuations they are getting one of which already is Tollovir for hospitalized patients.
Bio Pickers 101:
First step of selling something is to know what it's worth
Second step, negotiate a good deal for both parties
The cash flow neutral was a pleasant surprise. I guess the stock analyst on CDS was blind once again
Oh and Todos owns the majority of 3CL Pharma and has the option to raise it from 52% to 60% with a royalty payment. Actually a better deal than what was first announced last year as it gives Todos more flexibility with the buyers or whoever is going to invest.
I bought some more Tollovid this morning
Bio Pickers 101:
First step of selling something is to know what it's worth
Second step, negotiate a good deal for both parties
The cash flow neutral was a pleasant surprise. I guess the stock analyst on CDS was blind once again
Oh and Todos owns the majority of 3CL Pharma and has the option to raise it from 52% to 60% with a royalty payment. Actually a better deal than what was first announced last year as it gives Todos more flexibility with the buyers or whoever is going to invest.
I bought some more Tollovid this morning
(2)
(0)
